The biggest challenges currently facing companion diagnostic advancement
Related Experiment Video
Updated: May 5, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
1DrugScan, Inc., Horsham, PA 19044, USA.
Abstract:
Low productivity in the pharmaceutical industry positions personalized medicine and companion diagnostics as an attractive approach. The oncology community is enthusiastic and optimistic that advances in molecular diagnostics have the potential to materialize the dream of personalized cancer therapy with the aim to: help the drug industry enhance the probability of success and, probably, accelerate time to market; help the diagnostics industry develop diagnostic tests utilizing precious human samples; and support accurate diagnosis and selection of the most efficacious and least toxic therapies. However, this spectacular road is not yet paved and remains facing the following biggest challenges: the need for better understanding of biology and limitations of preclinical models; pre-analytical variables that are likely to alter results; analytical discrepancies; and the wide gap between clinical/pharmaceutical and diagnostic understandings. This article explores these challenges, their possible impacts, and provides some suggestions for mitigation.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
05:33Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Related Concept Videos
Automated Microbial Diagnostics
Pharmacogenomics: Identification of New Drug Targets
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Cardiomyopathy V: Interprofessional Care
Preclinical Development: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...